ADRA2A antibody (C-Term) (Magnetic Particles)

Catalog No. ABIN1492950

The Magnetic Particles-conjugated Rabbit Polyclonal anti-ADRA2A antibody (ABIN1492950) specifically detects ADRA2A in IP. The antibody is reactive with Human, Rat and Mouse samples.

Quick Overview for ADRA2A antibody (C-Term) (Magnetic Particles) (ABIN1492950)

Target: ADRA2A (Alpha-2A Adrenergic Receptor (ADRA2A))

Reactivity: Human, Rat, Mouse

Host: Rabbit

Clonality: Polyclonal

Conjugate: This ADRA2A antibody is conjugated to Magnetic Particles

Application: Immunoprecipitation (IP)

Product Details anti-ADRA2A Antibody (Magnetic Particles)

Binding Specificity: C-Term

Specificity: Human, mouse, rat. No cross reactivity with other proteins.

Cross-Reactivity (Details): No cross reactivity with other proteins.

Purification: Immunoaffinity purified

Immunogen: Synthetic peptide corresponding to a sequence mapping near the C-terminal of human ADRA2, identical to the related rat and mouse sequence.

Type of Immunogen: Synthetic peptide

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Comment:

Target Species of Antibody: Human

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: 1 mg/mL magnetic beads in PBS,  pH 7.2, 0.05 mg sodium azide

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: 4 °C

Storage Comment: Store at 4°C.

Target Details for ADRA2A

Target: ADRA2A (Alpha-2A Adrenergic Receptor (ADRA2A))

Alternative Name: ADRA2A

Background: Name/Gene ID: ADRA2A
Subfamily: Adrenergic
Family: GPCR

Synonyms: ADRA2A, Alpha-2A adrenoreceptor, Alpha-2AAR, Alpha-2AAR subtype C10, ADRA2, ADRA2R, ADRAR, Adrenoceptor alpha 2A, Alpha 2a, Alpha(2A)-AR, Alpha2a, ALPHA2AAR, Alpha-2A adrenoceptor, Adrenergic alpha 2a receptor, Adrenergic alpha 2a receptor, Alpha-2A adrenergic receptor

Gene ID: 150

UniProt: P08913

Pathways: EGFR Signaling Pathway, Negative Regulation of Hormone Secretion, Carbohydrate Homeostasis, cAMP Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Negative Regulation of Transporter Activity